GGrantIndex
← Leaderboards

Evan Michael Graboyes

Medical University Of South Carolina

$7,185,529
Attributed
$9,656,943
Total exposure
7
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.7M · FY201925
$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,656,943 · 7

By mechanism

R01$4,060,425 · 3
UG1$1,986,754 · 1
R37$1,890,046 · 1
K08$1,332,745 · 1
R21$386,973 · 1

Most similar at Medical University Of South Carolina

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Caring

Research focus

CaringRandomizedSiteCare DeliveryClinical CareProviderHead And Neck CancerEvidence BaseInterviewAffectCessation Of LifeTreatment As UsualCancer CareEnrollmentPatient PopulationCancer TherapyCancer TypeChemotherapyProgramsScreeningTrainingAdjuvant TherapyHead And Neck SurgeryPostoperative Period

Grant awards (17)

Medical University of South Carolina NCORP Community Site$1,038,731
UG1 · FY2025 · CA
Evaluation of a Proactive Identification and Digital Mental Health Intervention Approach to Address Unmet Psychosocial Needs of Individuals Living with Likely Incurable Cancer$711,787
R01 · FY2025 · CA
A Type I Hybrid Effectiveness-Implementation Trial to Evaluate a Navigation-Based Multilevel Intervention to Decrease Delays Starting Adjuvant Therapy Among Patients with Head and Neck Cancer$690,864
R01 · FY2025 · CA · contact PI
A Randomized Controlled Trial to Evaluate a Novel Treatment Strategy for Body Image-Related Distress Among Head and Neck Cancer Survivors$631,830
R37 · FY2025 · CA · contact PI
Optimizing Treatment for Human Papillomavirus-Associated Oropharyngeal Cancer in Older Adults$629,179
R01 · FY2025 · CA
Medical University of South Carolina NCORP Minority/Underserved Community Site$948,023
UG1 · FY2024 · CA
A Type I Hybrid Effectiveness-Implementation Trial to Evaluate a Navigation-Based Multilevel Intervention to Decrease Delays Starting Adjuvant Therapy Among Patients with Head and Neck Cancer$655,170
R01 · FY2024 · CA · contact PI
Evaluation of a Proactive Identification and Digital Mental Health Intervention Approach to Address Unmet Psychosocial Needs of Individuals Living with Likely Incurable Cancer$621,732
R01 · FY2024 · CA
A Randomized Controlled Trial to Evaluate a Novel Treatment Strategy for Body Image-Related Distress Among Head and Neck Cancer Survivors$600,063
R37 · FY2024 · CA · contact PI
A Type I Hybrid Effectiveness-Implementation Trial to Evaluate a Navigation-Based Multilevel Intervention to Decrease Delays Starting Adjuvant Therapy Among Patients with Head and Neck Cancer$751,693
R01 · FY2023 · CA · contact PI
A Randomized Controlled Trial to Evaluate a Novel Treatment Strategy for Body Image-Related Distress Among Head and Neck Cancer Survivors$658,153
R37 · FY2023 · CA · contact PI
Improving the Timeliness and Equity of Adjuvant Therapy Following Surgery for Head and Neck Cancer$266,549
K08 · FY2023 · CA · contact PI
Improving the Timeliness and Equity of Adjuvant Therapy Following Surgery for Head and Neck Cancer$266,549
K08 · FY2022 · CA · contact PI
Improving the Timeliness and Equity of Adjuvant Therapy Following Surgery for Head and Neck Cancer$266,549
K08 · FY2021 · CA · contact PI
A Novel Treatment Strategy for Body Image Disturbance in Head and Neck Cancer Survivors$386,973
R21 · FY2020 · CA · contact PI
Improving the Timeliness and Equity of Adjuvant Therapy Following Surgery for Head and Neck Cancer$266,549
K08 · FY2020 · CA · contact PI
Improving the Timeliness and Equity of Adjuvant Therapy Following Surgery for Head and Neck Cancer$266,549
K08 · FY2019 · CA · contact PI